Status:
COMPLETED
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
Lead Sponsor:
National Institute of Environmental Health Sciences (NIEHS)
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18+ years
Brief Summary
Systemic lupus erythematosus (SLE) is severe, chronic, disabling autoimmune disease that significantly affects health status and quality of life. Since the disease occurs most often in young to middle...
Detailed Description
Systemic lupus erythematosus (SLE) is severe, chronic, disabling autoimmune disease that significantly affects health status and quality of life. Since the disease occurs most often in young to middle...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients were eligible for the study if they met the 1997 revised American College of Rheumatology classification criteria for SLE (32, 33), were diagnosed between January 1, 1995 and July 31, 1999, were 18 years or older at study enrollment, had lived within the study area during at least 6 months of the year prior to diagnosis, and could speak and understand English.
Exclusion
Key Trial Info
Start Date :
December 17 1996
Trial Type :
OBSERVATIONAL
End Date :
March 7 2007
Estimated Enrollment :
640 Patients enrolled
Trial Details
Trial ID
NCT00342095
Start Date
December 17 1996
End Date
March 7 2007
Last Update
July 2 2017
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599-7030
2
Duke University Medical Center
Durham, North Carolina, United States, 27710
3
East Carolina University
Greenville, North Carolina, United States, 27858-4354
4
Wake Medical Center
Raleigh, North Carolina, United States